Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 32, 2024 - Issue 5
Submit an article Journal homepage
101
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon

L. De Simonea Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, ItalyView further author information
,
P. Gentileb Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, ItalyView further author information
,
R. Aldigeric Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
,
V. Mastrofilippoa Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, ItalyView further author information
,
E. Bollettaa Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, ItalyView further author information
,
F. Gozzia Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, ItalyView further author information
,
C. Adania Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, ItalyORCID Iconhttps://orcid.org/0000-0002-2477-5463View further author information
ORCID Icon,
C. Salvaranid Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy;e Division of Rheumatology, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, ItalyView further author information
&
L. Ciminoa Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy;d Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7956-9950View further author information
ORCID Icon show all
Pages 678-682 | Received 20 Sep 2022, Accepted 21 Mar 2023, Published online: 24 Apr 2023

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohammad Avarand, Mine Esen Baris, Leila Taheri & Suzan Guven Yılmaz. (2023) Efficacy of Pegylated Interferon Alpha-2a in Uveitic Macular Edema Refractory to Biologic Agents. Ocular Immunology and Inflammation 31:10, pages 1900-1905.
Read now
Lingling Huang, Christina Flaxel, Eric Suhler & Phoebe Lin. (2023) Two Cases of Chronic Central Serous Chorioretinopathy Successfully Treated with Systemic Interferon Alpha. Ocular Immunology and Inflammation 0:0, pages 1-10.
Read now

Articles from other publishers (1)

Karoline Baquet-Walscheid, Thomas Rath & Arnd Heiligenhaus. (2024) Augenbeteiligung bei ausgewählten rheumatischen Erkrankungen – Klinik im Erwachsenenalter. Klinische Monatsblätter für Augenheilkunde 241:05, pages 626-632.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.